Resources & Reports

The Drug Enforcement Administration (DEA) has published two proposed regulations to address how telehealth may be used to prescribe controlled substances in a post-PHE environment. The DEA is proposing new exceptions that along with what is already in current law, will open up more ways for telehealth to be used to prescribe a controlled substance, but they are highly specific. At this point, these are only proposed rules, but the deadline to submit public comment is quickly approaching.  View the PPT here.

Executive Director, Mei Kwong, provides a brief recap of state and federal telehealth policy in 2022 and what to look forward to in a post-PHE environment. View the PPT here.

This video addresses the most frequently asked questions CCHP receives regarding licensure and telehealth for example: (1) What does the law says if your patient is going on vacation to another state, but still needs your services? (2) Do you really need a license in another state if you’re just consulting with a provider who is already licensed in that state? (3) ….and many more!  View the PPT for this video here.

This video will cover the proposed telehealth policy changes for Medicare that CMS is making for CY 2023.   View the PPT for this video here.

This video will look at where telehealth policy may be when the federal public health emergency is declared over. View the PPT for this video here: